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NC-ND license (http://creativecommoSummary Background: Factors affecting liver regeneration are still relevant. The purpose of
this study is to investigate the effect of nebivolol treatment on liver regeneration in rats in
which 70% partial hepatectomy was performed.
Methods: Three groups were created: the control group, the low dose group, and the high dose
group, with 20 rats in each group and 70% hepatectomy was performed in all rats. Immediately
after partial liver resection, 2 mL physiological saline solution was administered to the control
group via oral gavage, 0.5 mg/kg nebivolol was administered via oral gavage to the low dose
group and 2 mg/kg nebivolol was administered via oral gavage to the high dose group. On
the 1st and 5th days after liver resection, 10 subjects were sacrificed from each group, and liver
weights and the mitotic count and Ki-67 were measured.
Results: Regenerating liver weight on the 1st and 5th days after partial hepatectomy was sta-
tistically different in the low dose and high dose nebivolol groups compared to the control
group. Mitotic count on the 1st day after partial hepatectomy was significantly higher in the
low dose and high dose nebivolol groups than the control group. There was no statistically sig-
nificant difference detected between the three groups for the 5th day. On the 1st day, Ki-67
rates were significantly higher in both groups given nebivolol than the control group. However,
5th day results were not statistically significant.
Conclusion: Nebivolol increases regeneration after partial hepatectomy in rats.
Copyright ª 2016, Asian Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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+ MODEL1. Introduction
The liver is an organ that has a known regeneration capa-
bility. Developments in surgical techniques have led to
rapid advances in liver surgery. Nowadays, the most
important limiting factor in liver surgery is liver failure
after major liver resections. The remaining liver tissue
after liver resection is capable of regeneration. This pro-
cess is a complex condition in which many different
mechanisms play a role.1,2 Many cytokines have a promot-
ing effect on regeneration, but besides this, some show
inhibitory effects.3,4 There are many studies related to
exposing liver regeneration steps and this topic still remains
up to date.
Nebivolol is a pharmacologic agent that is clinically used
as an antihypertensive. It is a third generation beta-1
adrenoreceptor antagonist. Unlike other drugs in the
same type, it blocks beta-1 adrenoreceptors selectively. It
is used a single daily dose. Nebivolol is metabolized in the
liver and excreted through the kidneys. It is clinically shown
that nebivolol is well tolerated and has fewer side effects
than the other beta-blockers.5 It does not increase pe-
ripheral vascular resistance like other beta adrenoreceptor
antagonists. Conversely, it creates vasodilation by
increasing vascular endothelial nitric oxide (NO) levels.6,7
The increasing vascular endothelial level of NO which is
produced in the liver has been shown to enhance the
regeneration of the liver.8 To our knowledge, there is no
other study that investigates the effects of nebivolol that
causes an increase in NO levels in vascular endothelium, on
liver regeneration. In this study, our aim is to investigate
the effects of different doses of nebivolol on liver regen-
eration in rats in which we performed 70% partial
hepatectomy.
2. Methods
After review of the literature, the study was approved by
the Ankara University Experimental Animal Ethics Com-
mittee on June 3, 2013 with 2013-6-46 decision number.
The experimental study was performed at the Experimental
Animal Research Laboratory of Ankara University Faculty of
Medicine in April 2013. In the study, 60 female Wistar Albino
rats, 8e10 weeks old, ranging in weight from 200 g to 250 g,
were fed with standard laboratory chow. Seventy percent
hepatectomy was performed in all rats. Physiological saline
solution (2 mL), 0.5 mg/kg nebivolol, and 2 mg/kg nebivolol
were administered via oral gavage to the control, low dose,
and high dose groups, respectively. Rats were divided into
three groups: Group 1 (control group, 2 mL oral gavage of
saline), Group 2 (low dose nebivolol group, 0.5 mg/kg oral
gavage), and Group 3 (high dose nebivolol group, 2 mg/kg
oral gavage).
Ketamine HCl (80 mg/kg) and 12 mg/kg xylazine hydro-
chloride were administered intramuscularly for anesthesia
and muscle relaxation. Laparotomy with a 2.5-cm midline
incision was performed in all rats. The pedicles of the left
lateral and median lobes of the liver were ligated with 4/Please cite this article in press as: Sumer F, et al., Effect of nebivolol
model, Asian Journal of Surgery (2016), http://dx.doi.org/10.1016/j.a0 silk and 70% hepatectomy was performed as described by
Higgins and Anderson.9 The removed livers were weighed
and the weight recorded. After controlling hemostasis, the
abdomen was closed with single layer sutures. The above-
mentioned doses of nebivolol and saline were given up to
24 hours prior to sacrification to the groups that will be
sacrificed on the 5th day after liver resection. On the 1st and
5th day after liver resection, 10 subjects from each group
were sacrificed by creating hypovolemia with drawing an
average of 6 mL blood from the inferior vena cava. Then,
the remaining liver tissue was removed, weighed and
placed in formol for pathological examination.
2.1. The weight of regenerating liver
Wet weights of removed left and median lobes were
weighed after partial resection (RW). Total liver weight
before resection (TW) was calculated by assuming 70% of
liver weight was resected (TW Z RW/0.7). The amount of
regeneration was calculated by dividing total liver weight
on the day of sacrifice (SW) to the calculated weight before
resection (SW/TW  100). This formula is known as Kwon
Formula, which derives from the name of the originator.10
2.2. Histological and immunohistochemical
evaluation
Histological and immunohistochemical evaluation was per-
formed in the Pathology Department of Tu¨rkiye Yu¨ksek
_Ihtisas Training and Research Hospital. Tissue samples were
fixed in 10% buffer formalin and mitosis were counted from
hematoxylineeosin-stained slides in 10 high power fields
(Olympus, CX31, Tokyo, Japan). Ratios are given as
percent.11 To determine Ki-67 expression, sections were
taken to the slides with poly-L-lysine. Ki-67 (SP6) (Neo-
markers, Fremont, CA, USA) immunohistochemically
stained with ready-to-use rabbit monoclonal antibody and
nuclear staining were counted in 1000 cells. Positively
stained nuclei were expressed as percent.
2.3. Statistical analysis
Data analysis was performed using SPSS for Windows 11.5
program (SPSS Inc., Chicago, Illinois, USA). Distribution of
continuous variables close to normal was investigated with
the Shapiro Wilk test and homogeneity of variances was
investigated by the Levene test. Descriptive statistics are
shown as median (minimumemaximum). To control the
Type I error in all possible multiple comparisons, Bonferroni
adjustment was made. According to the Bonferroni
adjustment, p < 0.025 was considered statistically signifi-
cant for the results.12
3. Results
3.1. Regeneration
Median (minimumemaximum) values of regeneration rates
of subjects for groups are shown in Table 1. At the end of
the 1st day, there was a statistically significant differenceon liver regeneration in an experimental 70% partial hepatectomy
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Table 1 Regeneration rates of groups at 1 and 5 days
after partial hepatectomy.
Groups 1 Day 5 Days
Control 42.2 (37.4e55.2)b,c 48.55 (42.2e60.6)b,c
Low dose
nebivolol
49.9 (44.3e60.8)b 81.82 (62.8e106.6)b
High dose
nebivolol
53.6 (42.8e65.5)c 80.38 (65.4e92.2)c
pa 0.007 <0.001
a According to the Bonferroni adjustment, p < 0.025 was
considered statistically significant for the results.
b Difference between control group and low dose group was
statistically significant (p < 0.025).
c Difference between control group and high dose group was
statistically significant (p < 0.025). Figure 1 Mitotic activity observed in hepatocytes (hema-
toxylin-eosin, 10  10).
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groups (p Z 0.007). At the end of the 5th day, there was a
statistically significant difference between the control
group and the low dose and high dose groups (p < 0.001).
3.2. Mitosis
When the mitotic count calculated under 10 high-power
field of microscope was examined at 1 and 5 days after
partial hepatectomy of the subjects, we determined that
mitotic count in low dose and high dose nebivolol groups
was significantly higher when compared to the control group
(p < 0.001). There was no significant difference between
the low dose and high dose nebivolol groups on the 1st day.
Statistical analysis of mitosis between the groups on the 5th
day showed no significant results (p Z 0.036; Table 2).
Histopathologic appearance is shown in Figure 1.
3.3. Ki-67 proliferation index
On the 1st day, there was a statistically significant differ-
ence between the control group and both the low dose and
high dose groups and also between the low dose and the
high dose groups (p < 0.001). However, on the 5th day, there
was no statistically significant difference when the groups
were compared with each other (p Z 0.343; Table 3).Table 2 Mitotic count of the groups on 1 and 5 days after
partial hepatectomy.
Groups 1 Day 5 Days
Control 1 (0e2)b,c 4 (3e12)
Low dose nebivolol 3 (2e4)b 2 (0e12)
High dose nebivolol 3 (1e6)c 2 (1e10)
p-valuea <0.001 0.036
a KruskaleWallis test, comparisons between groups on 1st and
5th days. According to the Bonferroni adjustment, p < 0.025 was
considered statistically significant for the results.
b Difference between control group and low dose group was
statistically significant (p < 0.001).
c Difference between control group and high dose group was
statistically significant (p < 0.001).
Please cite this article in press as: Sumer F, et al., Effect of nebivolol
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Figure 2.4. Discussion
Weight measurement, prolifering cell nuclear antigen
(PCNA), and the mitotic index are the most commonly used
parameters for the evaluation of liver regeneration. Also,
DNA synthesis, cell proliferation, mitochondrial activity,
DNA thymidine content, micro RNA, 5-bromo-2-
deoxyuridine, plasma fibronectin level, p53, and a stimu-
latory substance can be used for evaluating regenera-
tion.13,14 Currently, mitotic count is the most widely used
proliferation index. In our study, we selected regeneration
weight ratio (according to Kwon formula), mitotic count,
and Ki-67 proliferation index for evaluating regeneration,
as they are also the most widely used in the literature.
Nebivolol is a third generation beta-adrenoreceptor
antagonist which has a double mechanism effect as an
antihypertensive, acting as a selective beta-1 blocker, and
increasing the level of vascular endothelial NO.15,16 In 2003,
Cominacini et al17 showed the increased levels of NO onTable 3 Ki-67 ratios of groups on 1st and 5th days after
partial hepatectomy.
Groups 1st Day 5th Day
Control 0 (0e1)b,c 3 (2e14)
Low dose 6 (2e41)b,d 2 (0e12)
High dose 2 (1e11)c,d 2 (1e10)
pa <0.001 0.343
a Kruskal Wallis test, comparisons between groups on 1st and
5th days. According to the Bonferroni adjustment, p < 0.025 was
considered statistically significant for the results.
b Difference between control group and low dose group was
statistically significant (p < 0.001).
c Difference between control group and high dose group was
statistically significant (p < 0.001).
d Difference between low dose group and high dose group was
statistically significant (p < 0.011).
on liver regeneration in an experimental 70% partial hepatectomy
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Figure 2 Nuclear staining in hepatocytes with Ki-67 immu-
nohistochemistry dye (10  10).
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studies suggesting that nebivolol increases NO production in
vascular endothelial cells by calcium independent path-
ways.18 Nebivolol is metabolized in the liver and its me-
tabolites increase production of NO in vascular endothelium
and induce vasodilatation. Beta-2 adrenergic receptors
promote the release of NO from the vascular endothelium.
Nebivolol has no inhibitory effect on the release of NO from
vascular endothelium, because it selectively blocks beta-1
receptors. Therefore, its effect is stronger.19 NO increases
hepatic microvascular blood flow without raising portal
pressure by inducing smooth muscle relaxation in the ter-
minal arterioles and portal vein, as well as relaxation of
presinusoidal stellate cells.20 Vasodilator effects of nitric
oxide are based on increase of the cGMP content in vascular
smooth muscle and the ability to sustain this effect. This
creates an antiapoptotic effect in the liver.21e23 There are
no studies investigating the effect of nebivolol on liver
regeneration. However, Teixeira et al24 investigated the
impact of nebivolol in rats with a bile duct ligation-induced
liver fibrosis model. In this study, they showed less liver
damage and increased survival rates in rats administered
nebivolol. Reiberg and colleagues25 suggested in a cirrhotic
rat model that treatment with nebivolol increases portal
pressure by increasing splanchnic blood flow. Considering
the mechanism described above, it can be expected that
the use nebivolol has a positive effect on liver regeneration
by increasing NO release and Cyclic 30, 50-Guanosine
Monophosphate (cGMP) production. We observed in the
literature that 0.5 mg/kg low dose and 2 mg/kg high dose
nebivolol administered via oral gavage can be used safely in
experimental studies evaluating nebivolol’s antihyperten-
sive efficacy and postmyocardial infarction remodeling we
also used low dose 0.5 mg/kg and high dose of 2 mg/kg of
nebivolol same as the literature.26
An article Kwon et al10 published in 1989 revealed that
liver regeneration velocity in 1 day is 44.7%, 3 days is 60.9%,
5 days is 75.9%, and 7 days is 86.2% in rats with 70% hepa-
tectomy, and administration of fibronectin and aprotinin
increases the rate of liver regeneration. This study showed
that significant increase in the weight measurements occurs
on the 5th day. Our study showed, in accordance with this,
ratios and regenerating liver weight on the 1st and 5th daysPlease cite this article in press as: Sumer F, et al., Effect of nebivolol
model, Asian Journal of Surgery (2016), http://dx.doi.org/10.1016/j.aafter partial hepatectomy were higher than in the control
group. Regeneration ratios were found to be significantly
higher than the control group in each drug group both on
the 1st and 5th days. These findings show that nebivolol
treatment increases liver regeneration at both doses. Also,
it was observed that the regeneration rate on the 5th day
was significantly higher than the 1st day in the groups
administered drug.
In an experimental model of partial hepatectomy,
Yardımcı and colleagues27 evaluated liver regeneration by
using sildenafil in their study and they showed that silden-
afil increases liver regeneration on the 1st and 5th days by
the NO pathway. Also Kurokawa et al28 created an experi-
mental model; they administered L-arginine as an NO donor
to rats with partial hepatectomy and suggested that L-
arginine increases liver regeneration. In our study, we
similarly suggest that nebivolol increases liver regeneration
by the NO pathway.
Mitotic activity is not observed in normal liver but it
increases in the liver mass loss or developing tissue damage
for any reason.29,30 This increase is more evident in rats in
the first 24e48 hours, then decreases after 72 hours. Laconi
et al31 demonstrated that numbers of mitotic cells are
much higher 24 and 48 hours after hepatectomy than 72 and
144 hours, in rats with 70% liver resection. Rai et al32
investigated the regeneration of liver in rats with partial
hepatectomy by using gadolinium chloride, and suggested
that mitotic index is significantly high corresponding to
regeneration.
In our study, when we evaluated the groups on the 1st
day according to mitotic count, we observed that the
mitosis rate was statistically higher in the low dose and high
dose drug groups compared to the control group, and the
difference was significant. This situation suggests that
mitosis starts quickly at the end of 24 hours due to use of
nebivolol. On the 5th day after partial hepatectomy, there
was no statistically significant difference between the
groups according to mitotic count. Also, it was observed
that higher mitotic count on the 1st day appears to decrease
on the 5th day, similar to the results of the hepatectomy
model of Kwon et al.10 Mitotic count of the control group
was higher than that of the drug groups on the 5th day, but
this was not statistically significant. The decrease of
mitotic count in drug groups on the 5th day after partial
hepatectomy suggests that regeneration comes to an end
and mitotic count decreases.
Ki-67 is a nuclear protein that shows correlation with cell
proliferation, and is thus used to measure hepatocyte
proliferation after partial hepatectomy. It is associated
with ribosomal RNA transcription in a cell cycle. Although it
is seen mostly in interphase, it can be seen in most of the
active phases of the cell cycle. There is no proliferation in
resting (G0) cells.33,34 In our study, there was a significant
difference between the control group and both the low
dose and high dose groups, and also between the low dose
and the high dose group, on the 1st day. This result shows
that regeneration increases in the early phase both in the
low dose and high dose groups, because Ki-67 reflects
proliferating cells that are out of G0 phase and in any phase
of the mitosis. Also, it is seen that proliferation is higher in
the low dose nebivolol group compared to the high dose
nebivolol group on the 1st day. This result suggests thaton liver regeneration in an experimental 70% partial hepatectomy
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the low and high dose groups, because Ki-67 reflects cell
count in any phase of the mitosis. The high level of Ki-67 in
drug groups compared to the control group on Day 1 and
similar levels on Day 5 was parallel to the mitotic count.
These findings seem to support each other. On the 1st day
after partial hepatectomy, the presence of high levels of Ki-
67 in the low dose group compared to the high dose group
can be considered as an unexpected finding. However, high
levels of Ki-67 in both groups is important to show the ef-
fect of the drug.
In conclusion, it was found that administration of both
low dose and high dose of nebivolol increases liver regen-
eration on the 1st and 5th days in a rat model of partial
hepatectomy. However, more clinical and experimental
studies are needed for routine use in humans.
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